Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenium Pharmaceuticals IncfiledCriticalMillenium Pharmaceuticals Inc
Priority to CR11242ApriorityCriticalpatent/CR11242A/en
Publication of CR11242ApublicationCriticalpatent/CR11242A/en
La presente invencion se refiere a nuevos compuestos empleados como inhibidores de proteasoma. La invencion tambien proporciona composiciones farmaceuticas que comprenden los compuestos de la invencion y metodos para usar las composiciones en el tratamiento de varias enfermedades.The present invention relates to new compounds employed as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods for using the compositions in the treatment of various diseases.
Process to produce an allergen extract; allergen extract; use of an allergen extract to treat peanut allergy; pharmaceutical composition comprising said extract; vaccine comprising an allergen extract.